在积极的中间分析后估计治疗效果的挑战
Yu Yang Soon1, Ian C Marschner2, Manjula Schou2
1NHMRC Clinical Trials Centre, University of Sydney, Sydney, NSW, Australia; Department of Radiation Oncology, National University Cancer Institute, Singapore, Singapore; Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
早期临床试验分析的治疗效果可能被高估. 处罚估计方法有助于纠正这种偏差,提高后续分析结果的可靠性,以免事件和整体存活.
科学领域:
- 临床试验 临床试验
- 生物统计学 生物统计学
- 瘤学研究研究
背景情况:
- 在随机临床试验 (RCT) 中,研究从初始积极的中间分析 (IA) 到随后的分析 (SA) 中减少治疗效应.
- 检查过高估计偏差,不成比例的风险和招聘异质性作为解释IA结果的关键挑战.
- 建议使用惩罚性估计方法来解决高估偏差的问题.
研究的目的:
- 了解为什么最初有益的治疗效果可能会因后续分析而减少.
- 评估过高估计偏差,不成比例风险和招聘异质性对治疗效果解释的影响.
- 评估惩罚性估计方法在纠正高估偏差方面的实用性.
主要方法:
- 确定了具有积极初始中间分析 (IA) 和随后分析 (SA) 的无事件生存率 (EFS) 和总生存率 (OS) 的瘤学RCT.
- 在IA与信息分数 (IF) 的模拟危险比率 (HR) 和HRIA与HRSA (rHR) 与IF的比率.
- 应用了惩罚性估计方法来调整HRIA的高估偏差.
主要成果:
- 最初的危险比率 (HRIA) 与信息分数 (IF) 有正相关.
- HRIA倾向于夸大后续危险比率 (HRSA),特别是在较低的IF.
- 使用处罚估计的调整HRIA没有显示HRSA的夸大,表明偏差纠正.
结论:
- 在解释临床试验中积极的中间分析时,高估偏差是重要的因素.
- 不成比例的风险和招聘异质性也会影响治疗效果的估计.
- 考虑这些因素和偏见纠正方法对于准确地传达试验结果至关重要.
更多相关视频
06:55Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
00:04A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
相关概念视频
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Assumptions of Survival Analysis
Comparing the Survival Analysis of Two or More Groups
Strategies for Assessing and Addressing Confounding
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
Sign Test for Matched Pairs
To conduct the sign test, we first calculate the differences in...
Statistical Significance
